As shown in Fig. 4b and Supplementary Fig. 12, ELISA and western blot analysis showed that NPTyr-C9AP treatment resulted in high expression of αPD-L1 protein in melanoma (57.82 ng g−1) enabling efficient PD-L1 blockade to enhance T-cell activation in the tumor microenvironment. This evidence concerns the gene CD274 and melanoma.